Search For "hematologic"
Glenmark and Ichnos take a collaborative leap to accelerate innovation in
Updated : 2 years, 1 month ago IST
Mumbai (Maharashtra) [India], January 31: Glenmark Pharmaceuticals Ltd. (Glenmark), a leading, research-driven, global pharmaceutical company, and Ichnos Sciences Inc. (Ichnos), its global fully integrated, clinical-stage biotech subsidiary, today announced the launch of their alliance - Ich
Read More
Study reveals factors for advanced stage AL amyloidosis outcomes
Updated : 5 months, 1 week ago IST
According to new research published in Blood Advances, early improvements in cardiac and hematologic parameters may predict better survival outcomes for patients being treated for stage IIIb AL amyloidosis, a deadly disease with a median survival of 4-6 months caused by abnormal protein buil
Read More
Researchers discover source of T cell exhaustion
Updated : 2 years, 11 months ago IST
CAR T-cell treatments, which are specifically designed to target cancer cells, has heralded a new era in the treatment of human cancers, particularly hematologic malignancies. But all too frequently, they exhibit a disconcerting characteristic derived from the immune system's own cells: a sh
Read More
Surat Hematology Centre - 1st Centre of Excellence for Hematology and Bone
Updated : 3 years, 3 months ago IST
New Delhi [India], November 17 (ANI/SRV): Surat Hematology Centre, a comprehensive diagnostic and treatment facility for Hematological malignancies and other blood disorders for both adults and children, has become the first centre of excellence in Hematology and Bone Marrow Transplant (BMT)
Read More
Study: Novel treatment effective for bladder cancer
Updated : 3 years, 5 months ago IST
Washington [US], October 8 (ANI): An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, reports a new study in mice. The drug is now being tested in a national clinical trial for pa
Read More
Study finds adults with blood cancer respond to booster dose of COVID-19 v
Updated : 3 years, 8 months ago IST
Washington [US], July 11 (ANI): According to a recent study, less than half of patients with hematologic malignancies developed detectable antibodies after the initial COVID-19 vaccination, but 56 per cent of "nonresponders" developed antibodies after receiving a booster dose.
Read More
New drug target for blood cancer, potentially solid tumours identified dur
Updated : 4 years, 5 months ago IST
New York [US], October 8 (ANI): The findings of a new study by Mount Sinai and UC San Diego researchers, for the first time, have shown how mutations affecting a cellular process called RNA splicing alter cells to develop myelodysplastic syndrome (MDS) and other hematologic malignancies and
Read More
BGS Gleneagles Global Hospitals pioneers day care Bone Marrow Transplant
Updated : 8 years, 6 months ago IST
Bengaluru (Karnataka) [India], May 27 (ANI): BGS Gleneagles Global Hospitals, a Parkway Pantai enterprise, successfully pioneered the day care Bone Marrow Transplant (BMT) transplant program for low risk transplants like autologous transplant for multiple myeloma and mini-allo transplant for
Read More